T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
85 hedge funds and large institutions have $181M invested in T2 Biosystems, Inc in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 16 reducing their positions, and 18 closing their positions.
94% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 16
14% more call options, than puts
Call options by funds: $1.09M | Put options by funds: $957K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 89 → 85 (-4)
11% less capital invested
Capital invested by funds: $203M → $181M (-$22.6M)
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.14M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$1.68M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.32M |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$1.19M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
-$7.39M |
| 2 |
Millennium Management
New York
|
-$4.08M |
| 3 |
Renaissance Technologies
New York
|
-$3.03M |
| 4 |
JP Morgan Chase
New York
|
-$2.4M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.14M |
TTOO Hedge Fund Activity: Q3 2018 in Review
85 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2018, worth a combined $181M — down 11% from $203M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of TTOO and 14 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 31 added.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $2.14M. The largest seller was Lagoda Investment Management, exiting entirely with an estimated $7.39M sold.
- 85 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2018, down from 89 in Q2 2018.
- Funds reported $181M of T2 Biosystems, Inc stock for Q3 2018, down 11% quarter-over-quarter.
- 14 funds opened new T2 Biosystems, Inc positions in Q3 2018 and 18 closed out, a net change of -4 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2018 was Schonfeld Strategic Advisors, an estimated $2.14M added.
- The largest T2 Biosystems, Inc seller in Q3 2018 was Lagoda Investment Management, an estimated $7.39M sold.
Based on aggregated 13F filings for Q3 2018.